Abstract
A novel series of 1,2,3-triazolo-benzodiazepine derivatives 6a–o has been synthesized and evaluated in vivo for their anticonvulsant activities using by pentylenetetrazole (PTZ)- and maximal electroshock (MES)-induced seizures in mice. The synthetic approach started with diazotizing 2-aminobenzoic acids 1 to produce 2-azidobenzoic acids 2. Next, reaction of the latter compounds with propargylamine 3, benzaldehyde 4, and isocyanides 5 led to the formation of the title compounds 6a–o, in good yields. All the synthesized compounds exhibited high anticonvulsant activity in the PTZ test, comparable to or better than the standard drug diazepam. Among the tested compounds, N-(tert-butyl)-2-(9-chloro-6-oxo-4H-[1,2,3]triazolo[1,5-a][1,4]benzodiazepin-5(6H)-yl)-2-(3-bromophenyl)acetamide 6h was the most potent compound in this assay. Moreover, compounds 6i and 6k showed excellent activity in MES test. Loss of the anticonvulsant effect of compound 6h in the presence of flumazenil in the PTZ test and appropriate interaction of this compound in the active site of benzodiazepine (BZD)-binding site of GABAA receptor confirm involvement of BZD receptors in the anticonvulsant activity of compound 6h.
Graphical abstract
A novel series of 1,2,3-triazolo-benzodiazepine derivatives 6a–o have been synthesized and evaluated in vivo for their anticonvulsant activities using by pentylenetetrazole (PTZ)- and maximal electroshock (MES)-induced seizures in mice. All the synthesized compounds exhibited high anticonvulsant activity, comparable to or better than the standard drug diazepam in the PTZ test and compounds 6i and 6k showed excellent activity in MES test. Flumazenil test and in silico docking study confirm involvement of benzodiazepine receptors in the anticonvulsant activity of these compounds.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Löscher W (1998) New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 342:1–13. https://doi.org/10.1016/S0014-2999(97)01514-8
Meador KJ (2003) Newer anticonvulsants: dosing strategies and cognition in treating patients with mood disorders and epilepsy. J Clin Psychiatry 64:30–34
Lin Z, Kadaba PK (1997) Molecular targets for the rational design of antiepileptic drugs and related neuroprotective agents. Med Res Rev 17:537–572. https://doi.org/10.1002/(SICI)1098-1128(199711)17
Riss J, Cloyd J, Gates J, Collins S (2008) Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand 118:69–86. https://doi.org/10.1111/j.1600-0404.2008.01004.x
Costa E, Guidotti A, Mao CC, Suria A (1975) New concepts on the mechanism of action of benzodiazepines. Life Sci 17:167–185. https://doi.org/10.1016/0024-3205(75)90501-9
Narayana B, Raj KV, Ashalatha BV, Kumari NS (2006) Synthesis of some new substituted triazolo[4,3-a][1,4]benzodiazepine derivatives as potent anticonvulsants. Eur J Med Chem 41:417–422. https://doi.org/10.1016/j.ejmech.2005.12.003
Biagi G, Giorgi I, Livi O, Scartoni V, Velo S, DeSantis B, Martinelli A, Martini C, Senatore G (1996) 1,2,3-Triazolo[1,5-a][1,3] benzodiazepine a new heterocyclic system: synthesis, benzodiazepine receptor binding and theoretical calculations. Il Farmaco 51:13–18
Hemming K, Chambers CS, Hamasharif MS, Joao H, Khan MN, Patel N, Airley R, Day S (2014) Azide based routes to tetrazolo and oxadiazolo derivatives of pyrrolobenzodiazepines and pyrrolobenzothiadiazepines. Tetrahedron 70:7306–7317. https://doi.org/10.1016/j.tet.2014.07.050
Mohapatra DK, Maity PK, Shabab M, Khan MI (2009) Click chemistry based rapid one-pot synthesis and evaluation for protease inhibition of new tetracyclic triazole fused benzodiazepine derivatives. Bioorg Med Chem Lett 19:5241–5245. https://doi.org/10.1016/j.bmcl.2009.06.107
Saeedi M, Mahdavi M, Foroumadi A, Shafiee A (2013) Synthesis of novel fused 4,5-dihydro-1,2,3-triazolo[1,5-a][1,4]benzodiazepine derivatives via four-component Ugi–Smiles-type reaction. Tetrahedron 69:3506–3510. https://doi.org/10.1016/j.tet.2013.02.023
Mahdavi M, Asadi M, Saeedi M, Rezaei Z, Moghbel H, Foroumadi A, Shafiee A (2012) Synthesis of novel 1,4-benzodiazepine-3,5-dione derivatives: reaction of 2-aminobenzamides under Bargellini reaction conditions. Synlett 23:2521–2525. https://doi.org/10.1055/s-0032-1317297
Noushini S, Mahdavi M, Firoozpour L, Moghimi S, Shafiee A, Foroumadi A (2015) Efficient multi-component synthesis of 1,4-benzodiazepine-3,5-diones: a Petasis-based approach. Tetrahedron 71:6272–6275. https://doi.org/10.1016/j.tet.2015.06.060
Donald JR, Martin SF (2011) Synthesis and diversification of 1,2,3-triazole-fused 1,4-benzodiazepine scaffolds. Org Lett 13:852–855. https://doi.org/10.1021/ol1028404
Oluwaseye A, Uzairu A, Shallangwa GA, Abechi SE (2018) Quantum chemical descriptors in the QSAR studies of compounds active in maxima electroshock seizure test. J King Saud Univ Sci. https://doi.org/10.1016/j.jksus.2018.02.009
Azam F, El-gnidi BA, Alkskas IA (2010) Combating oxidative stress in epilepsy: design, synthesis, quantum chemical studies and anticonvulsant evaluation of 1-(substituted benzylidene/ethylidene)-4-(naphthalen-1-yl) semicarbazides. Eur J Med Chem 45:2817–2826. https://doi.org/10.1016/j.ejmech.2010.02.063
Navidpour L, Shafaroodi H, Miri R, Dehpour AR, Shafiee A (2004) Lipophilic 4-imidazoly-1,4-dihydropyridines: synthesis, calcium channel antagonist activity and protection against pentylenetetrazole-induced seizure. Il Farmaco 59:261–269. https://doi.org/10.1016/j.farmac.2003.11.013
Shafaroodi H, Moezi L, Fakhrzad A, Hassanipour M, Rezayat M, Dehpour AR (2012) The involvement of nitric oxide in the anti-seizure effect of acute atorvastatin treatment in mice. Neurol Res 34:847–853. https://doi.org/10.1179/1743132812Y.0000000080
Dehestani L, Ahangar N, Hashemi SM, Irannejad H, Masihi PH, Shakiba A, Emami S (2018) Design, synthesis, in vivo and in silico evaluation of phenacyl triazole hydrazones as new anticonvulsant agents. Bioorg Chem 78:119–129. https://doi.org/10.1016/j.bioorg.2018.03.001
Mohammadi-Khanaposhtani M, Shabani M, Faizi M, Aghaei I, Jahani R, Sharafi Z, Zafarghandi NS, Mahdavi M, Akbarzadeh T, Emami S, Shafiee A (2016) Design, synthesis, pharmacological evaluation, and docking study of new acridone-based 1,2,4-oxadiazoles as potential anticonvulsant agents. Eur J Med Chem 112:91–98. https://doi.org/10.1016/j.ejmech.2016.01.054
El-Subbagh HI, Hassan GS, El-Azab AS, Alaa AM, Kadi AA, Al-Obaid AM, Al-Shabanah OA, Sayed-Ahmed MM (2011) Synthesis and anticonvulsant activity of some new thiazolo[3,2-a][1,3]diazepine, benzo[d]thiazolo[5,2-a][12,6]diazepine and benzo[d]oxazolo[5,2-a][12,6]diazepine analogues. Eur J Med Chem 46:5567–5572. https://doi.org/10.1016/j.ejmech.2011.09.021
Acknowledgements
This work was supported by Grants from the National Institute for Medical Research Development (NIMAD) (Grant Number: 971149).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors have declared no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Shafie, A., Mohammadi-Khanaposhtani, M., Asadi, M. et al. Novel fused 1,2,3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluations. Mol Divers 24, 179–189 (2020). https://doi.org/10.1007/s11030-019-09940-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11030-019-09940-9